Universal Health (UHS)
NYSE:UHS
Want to see UHS full AI Analyst Report?
Earnings Data
Report Date
Jul 27, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
5.85Last Year’s EPS
5.35Same Quarter Last Year
Moderate Buy
Based on 13 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a largely positive operational and financial picture: solid top-line growth (revenue +9.6%), strong adjusted EBITDA and EPS growth, healthy operating cash flow, active share repurchases, and a strategically significant, expectedly accretive Talkspace acquisition that accelerates outpatient behavioral capabilities. Offsetting these positives were near-term volume headwinds driven by weaker flu season and winter weather, a meaningful and evolving HIX (exchange) headwind with conservatively reserved bad debt exposure (management reiterated a $75 million full-year impact), tougher prior-period supplemental payment comparisons that pressured core EBITDA in the quarter, and ongoing behavioral staffing/wage pressures and first-year losses at de novo hospitals. Overall, management reiterated guidance and emphasized expense discipline, margin initiatives (including AI), and M&A integration plans, and the balance of strong financial metrics and strategic actions outweighs the identified near-term headwinds.Company Guidance
Revenue and Earnings Growth
Consolidated revenue grew 9.6% year-over-year in Q1 2026. Adjusted EBITDA (net of NCI) increased 8.4% and adjusted EPS rose 16.1% versus Q1 2025. Reported net income attributable to UHS per diluted share was $5.65 and adjusted EPS was $5.62.
Strong Acute Segment Pricing and EBITDA
Acute care same-facility net revenues increased 8.2% (6.2% excluding health plan impact). Same-facility revenue per adjusted admission rose 6.3% (4.9% after excluding ~$30M prior-period supplemental program benefit). Same-facility acute segment EBITDA grew 11.7%.
Behavioral Segment Momentum
Behavioral health same-facility net revenues increased 7.3% with same-facility revenue per adjusted patient day up 5.8% and adjusted patient days up 1.6%. Same-facility behavioral segment EBITDA increased 8.4% (normalized core behavioral EBITDA growth ~4.3% after excluding prior-period supplemental payments).
Talkspace Acquisition — Strategic and Financial Upside
Announced acquisition of Talkspace (network of ~6,000 clinicians across all 50 states). Management expects the deal to be accretive to earnings in the first 12 months post-close and increasingly accretive thereafter, with an expected effective EBITDA multiple in the single digits by year three. Strategic rationale includes accelerating virtual outpatient capabilities and bidirectional revenue synergies (e.g., virtual IOPs).
Operating Cash Flow, CapEx, and Capital Return
Operating cash flow for Q1 2026 was $402 million versus $360 million in Q1 2025. Capital expenditures were $217 million for the quarter. The company repurchased 675,000 shares for $127 million in Q1 and has $1.3 billion of repurchase authorization remaining; management reiterated an annual buyback target of at least $800–$900 million.
Balance Sheet and Liquidity Actions
Expanded aggregate credit facility capacity by $900 million to support the pending Talkspace transaction and M&A flexibility. Revolver borrowings were $373 million as of 03/31/2026 and revolver capacity was expanded to $1.5 billion.
Margin and Expense Discipline
Same-facility acute salaries, wages and benefits expense per adjusted admission rose 3.1% and supply expense per adjusted admission rose 3.5%, while contract labor in acute was 2.3% of segment revenues (40 bps lower Y/Y). Management emphasized expense control, pricing contribution, and operational efficiency driving results.
AI and Digital Deployment
Deployed and scaled eight AI use cases in revenue cycle operations in 2025 (improving denials management and revenue capture). 2026 roadmap focuses on clinical AI use cases (patient experience and hospital-level efficiency) with partners such as Hippocratic AI; management expects incremental margin and quality benefits over time.
UHS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
UHS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 27, 2026 | $179.51 | $162.54 | -9.45% |
Feb 25, 2026 | $230.51 | $204.13 | -11.44% |
Oct 27, 2025 | $213.65 | $218.93 | +2.47% |
Jul 28, 2025 | $154.50 | $162.35 | +5.08% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Universal Health (UHS) report earnings?
Universal Health (UHS) is schdueled to report earning on Jul 27, 2026, After Close (Confirmed).
What is Universal Health (UHS) earnings time?
Universal Health (UHS) earnings time is at Jul 27, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is UHS EPS forecast?
UHS EPS forecast for the fiscal quarter 2026 (Q2) is 5.85.
